Summary

The sample “Viamed 20” from DEUS Medical underwent qualitative and quantitative analysis. Testing confirmed the presence of Sildenafil Citrate with measured concentrations of 19.46 mg in the first pill and 19.88 mg in the second pill.

Testing was ordered and conducted on 7-8 July 2020.


Detailed Report

Product Overview

Sample Acquisition and Testing

Testing Results


Verification Details


Evaluation of Reseller-Submitted Testing

The test confirms the presence of Sildenafil Citrate in the Viamed 20 pills with minor dosage variations (19.46 mg and 19.88 mg), which are within acceptable manufacturing tolerances for pharmaceuticals.


Conclusion

The results validate the presence and dosage of Sildenafil Citrate in the sample, demonstrating compliance with the expected formulation standards.


Disclaimer

This report is for informational purposes and reflects findings based on reseller-submitted testing. Independent third-party analysis is recommended for thorough validation.